CHYHY:OTC-Chr. Hansen Holding A/S (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 21.57

Change

-0.44 (-2.00)%

Market Cap

USD 11.55B

Volume

0.02M

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. It operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The company was founded in 1874 and is headquartered in Hørsholm, Denmark.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-02-23 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SKFOF Sika AG

-10.00 (-3.57%)

USD39.50B 61.99 32.37
SXYAY Sika AG

-0.90 (-3.24%)

USD39.42B 61.55 33.55
GVDNY Givaudan SA

-1.23 (-1.54%)

USD36.72B 51.80 31.39
GVDBF Givaudan SA

N/A

USD36.72B 52.22 30.49
KDSKF Koninklijke DSM N.V

-2.21 (-1.30%)

USD29.49B 25.99 38.28
RDSMY Koninklijke DSM N.V

-0.14 (-0.31%)

USD29.49B 26.33 38.28
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD26.41B 95.63 0.28
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.79B 42.35 41.44
AKZOF Akzo Nobel N.V

-0.14 (-0.13%)

USD19.93B 25.40 16.55
AKZOY Akzo Nobel N.V

+0.24 (+0.69%)

USD19.74B 31.18 16.55

ETFs Containing CHYHY

Symbol Name Weight Mer Price(Change) Market Cap
RFDI First Trust RiverFront Dy.. 0.00 % 0.83 %

-0.17 (-0.26%)

USD0.15B
ORG The Organics ETF 0.00 % 0.35 %

N/A

USD6.05M
EXSD:F iShares STOXX Europe Mid .. 0.00 % 0.21 %

-0.38 (-0.74%)

USD0.29B
EXSD:XETRA iShares STOXX Europe Mid .. 0.00 % 0.21 %

-0.26 (-0.51%)

USD0.44B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.68% 3% F 9% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.68% 3% F 9% F
Trailing 12 Months  
Capital Gain 17.04% 32% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.04% 31% F 47% F
Trailing 5 Years  
Capital Gain 39.07% 43% F 50% F
Dividend Return 7.90% 33% F 29% F
Total Return 46.97% 43% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 15.07% 68% D+ 63% D
Dividend Return 1.46% 44% F 40% F
Total Return 16.53% 65% D 62% D-
Risk Return Profile  
Volatility (Standard Deviation) 24.68% 58% F 66% D
Risk Adjusted Return 67.00% 84% B 91% A-
Market Capitalization 11.55B 77% C+ 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.85 46% F 35% F
Price/Book Ratio 10.50 13% F 16% F
Price / Cash Flow Ratio 31.69 13% F 7% F
EV/EBITDA 44.98 7% F 10% F
Management Effectiveness  
Return on Equity 26.79% 95% A 94% A
Return on Invested Capital 21.41% 88% B+ 84% B
Return on Assets 7.69% 87% B+ 92% A-
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.08 89% B+ 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector